ロード中...
Extended-release injectable naltrexone for opioid use disorder: A systematic review
AIMS: To review systematically the published literature on extended-release naltrexone (XR-NTX, Vivitrol®), marketed as a once-per-month injection product to treat opioid use disorder. We addressed the following questions: (1) How successful is induction on XR-NTX?; (2) What are adherence rates to X...
保存先:
| 出版年: | Addiction |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5993595/ https://ncbi.nlm.nih.gov/pubmed/29396985 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/add.14180 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|